Capture SBIR Licensing Spread via NASA Anomaly Detection Patent Bridge
- Organization
- NASA Ames Research Center
- Sector
- Medical Device Manufacturers pursuing SBIR/STTR funding
- Location
- United States
Source reference
Executive summary
Current state
NASA's patented Inductive Monitoring System anomaly detection technology is available for licensing with active SBIR/STTR funding pathways, but lacks commercial deployment infrastructure and medical domain adaptation, creating arbitrage opportunities between NASA's low upfront fees and substantial government funding available to licensees.
Market catalyst
NASA's 'case-by-case' licensing negotiation creates uncertainty and delay for SBIR applicants who need guaranteed technology access for their funding proposals, while NASA's low upfront fees ($5-10K) are dwarfed by the $1.8M SBIR Phase II funding available to licensees.
This report is synthesized intelligence, not verified instruction. Always confirm against the primary source before acting. Review the full legal disclaimer before proceeding.
Field notes
Intelligence ledger
Add new evidence, corrections, or practical context to this directive. Keep claims attributable to a source where possible.
Sign in to add intelligence or vote on a field note.
Field intel logs: [ 0 ] entries. No operative updates submitted for this directive. Submit intel to claim clearance.